Skip to main content

Table 3 Kaplan-Meier analysis of mortality post-ACS for 89 genetic variants.

From: Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome

Gene/SNP

Genotype

Total N

Deaths (%)

P

Gene

Genotype

Total N

Deaths (%)

P

ABCA1

CC

191

18 (9.4)

0.50

ICAM1

AA

270

43 (15.9)

0.01

-477C/T

CT

396

43 (10.9)

 

Lys469Glu

AG

379

32 (8.4)

 
 

TT

188

25 (13.3)

  

GG

145

14 (9.7)

 

ABCA1

AA

65

7 (10.8)

0.47

IL1B

CC

359

35 (9.8)

0.42

Lys219Arg

AG

311

39 (12.5)

 

-511C/T

CT

311

33 (10.6)

 
 

GG

416

41 (9.9)

  

TT

82

12 (14.6)

 

ACE1

DD

233

28 (12)

0.04

IL6

CC

142

16 (11.3)

0.59

I/D

DI

389

35 (9)

 

-174G/C

CG

386

39 (10.1)

 
 

II

154

25 (16.2)

  

GG

277

35 (12.6)

 

ADD1

GG

456

59 (12.9)

0.23

IRS1

AA

3

2 (66.7)

0.001

Gly460Trp

GT

269

25 (9.3)

 

Gly972Arg

AG

84

4 (4.8)

 
 

TT

26

2 (7.7)

  

GG

704

81 (11.5)

 

ADRB2

CC

266

36 (13.5)

0.19

ITGA2

AA

123

17 (13.8)

0.46

Glu27Gln*

CG

358

33 (9.2)

 

Phe807Phe

AG

394

45 (11.4)

 
 

GG

146

15 (10.3)

  

GG

288

28 (9.7)

 

ADRB2

CC

789

89 (11.3)

0.41

ITGB3

CC

20

3 (15)

0.89

Ile164Thr

CT

18

1 (5.6)

 

Leu33Pro

CT

188

21 (11.2)

 
 

TT

    

TT

588

64 (10.9)

 

ADRB2

AA

128

21 (16.4)

0.09

LIPC

CC

506

59 (11.7)

0.79

Gly16Arg

AG

348

36 (10.3)

 

-514T/C

CT

256

26 (10.2)

 
 

GG

309

31 (10)

  

TT

42

5 (11.9)

 

ADRB3

CC

6

1 (16.7)

0.53

LPL

AG

29

3 (10.3)

0.93

Arg64Trp

CT

111

16 (14.4)

 

Asp9Asn

GG

765

86 (11.2)

 
 

TT

687

72 (10.5)

  

GG

   

AGT

CC

143

19 (13.3)

0.19

LRP1

AA

367

37 (10.1)

0.08

Thr235Met

CT

387

48 (12.4)

 

Thr3261Thr

AG

330

46 (13.9)

 
 

TT

272

23 (8.5)

  

GG

85

5 (5.9)

 

AGTR1

AA

388

48 (12.4)

0.56

LTA

AA

394

44 (11.2)

0.52

A1166C

AC

339

34 (10)

 

A252G

AG

327

38 (11.6)

 
 

CC

79

8 (10.1)

  

GG

81

6 (7.4)

 

ALOX5AP

A

123

12 (9.8)

0.61

LTA

AA

80

6 (7.5)

0.51

HAP A

non-A

648

74 (11.4)

 

Thr26Asn

AC

331

39 (11.8)

 
      

CC

389

44 (11.3)

 

ALOX5AP

B

49

3 (6.1)

0.23

MGP

AA

308

36 (11.7)

0.81

HAP B

non-B

722

83 (11.5)

 

Thr83Ala

AG

374

39 (10.4)

 
      

GG

123

15 (12.2)

 

APOA1

AA

23

2 (8.7)

0.91

MGP

AA

110

13 (11.8)

0.61

C83T

AG

219

25 (11.4)

 

-7A/G

AG

368

37 (10.1)

 
 

GG

532

59 (11.1)

  

GG

328

40 (12.2)

 

APOA1

AA

1

1 (100)

0.01

MMP3

DD

194

20 (10.3)

0.22

-75G/A

AG

10

1 (10)

 

indel

DI

386

37 (9.6)

 
 

GG

784

87 (11.1)

  

II

206

29 (14.1)

 

APOE

E4/E4

29

1 (3.5)

0.20

MTHFR

CC

350

39 (11.1)

0.53

E2-3-4

Non-E4

771

87 (11.3)

 

Ala222Val

CT

341

40 (11.7)

 
      

TT

102

8 (7.8)

 

APOE

GG

194

25 (12.9)

0.42

MTP

GG

449

54 (12)

0.13

-219T/G

GT

403

47 (11.7)

 

-493G/T

GT

297

33 (11.1)

 
 

TT

206

18 (8.7)

  

TT

59

2 (3.4)

 

BDKRB2

CC

263

25 (9.5)

0.40

MTR

AA

529

56 (10.6)

0.15

-58C/T

CT

394

50 (12.7)

 

Asp919Gly

AG

239

32 (13.4)

 
 

TT

145

14 (9.7)

  

GG

34

1 (2.9)

 

CCL11

CC

539

64 (11.9)

0.76

NPPA

CC

22

2 (9.1)

0.65

Thr23Ala

CT

239

24 (10)

 

Ter29ArgArg

CT

190

18 (9.5)

 
 

TT

12

1 (8.3)

  

TT

583

70 (12)

 

CCR2

AA

7

1 (14.3)

0.96

OLR1

CC

649

75 (11.6)

0.27

Val64Ile

AG

116

12 (10.3)

 

Lys167Asn

CG

146

12 (8.2)

 
 

GG

681

77 (11.3)

  

GG

8

2 (25)

 

CCR5

II

631

72 (11.4)

0.51

P22-PHOX

CC

347

26 (7.5)

0.05

Indel

ID

162

18 (11.1)

 

His72Tyr**

CT

271

36 (13.3)

 
 

DD

12

0 (0)

  

TT

121

15 (12.4)

 

CD14

CC

204

25 (12.3)

0.22

PAI1

DD

249

32 (12.9)

0.33

-159C/T

CT

395

47 (11.9)

 

indel

DI

398

38 (9.6)

 
 

TT

204

16 (7.8)

  

II

159

20 (12.6)

 

CETP

AA

168

13 (7.7)

0.13

PECAM1

CC

187

21 (11.2)

0.86

intron1 G/A

AG

387

51 (13.2)

 

Leu125Val

CG

395

42 (10.6)

 
 

GG

250

25 (10)

  

GG

222

27 (12.2)

 

CETP

AA

205

18 (8.8)

0.39

PECAM1

AA

200

25 (12.5)

0.82

-629C/A

AC

400

50 (12.5)

 

Ser563Asn

AG

386

42 (10.9)

 
 

CC

197

21 (10.7)

  

GG

214

22 (10.3)

 

COMT

AA

231

17 (7.4)

0.06

PON1

AA

396

36 (9.1)

0.09

Val158Met

AG

358

43 (12)

 

Gln192Arg

AG

337

47 (14)

 
 

GG

187

27 (14.4)

  

GG

66

6 (9.1)

 

CX3CR1

CC

410

43 (10.5)

0.54

PON2

CC

464

56 (12.1)

0.43

Ile249Val

CT

336

40 (11.9)

 

Cys311Ser

CG

298

28 (9.4)

 
 

TT

56

4 (7.1)

  

GG

40

3 (7.5)

 

CX3CR1

AA

18

1 (5.6)

0.73

PPARG

CC

637

73 (11.5)

0.32

Thr280Met

AG

223

26 (11.7)

 

Ala12Pro

CG

159

15 (9.4)

 
 

GG

565

63 (11.2)

  

GG

8

2 (25)

 

CYP11B2

CC

163

18 (11)

0.84

PTGS2

CC

15

2 (13.3)

0.94

-344T/C

CT

352

42 (11.9)

 

-765G/C

CG

202

22 (10.9)

 
 

TT

275

29 (10.6)

  

GG

576

65 (11.3)

 

CYP2C9

AA

708

79 (11.2)

0.89

RECQL2

CC

66

11 (16.7)

0.18

Leu359Ile

AC

56

6 (10.7)

 

Arg1367Cys

CT

326

39 (12)

 
 

CC

    

TT

412

39 (9.5)

 

CYP2C9

CC

589

63 (10.7)

0.83

SELE

CC

658

71 (10.8)

0.43

Cys144Arg**

CT

147

15 (10.2)

 

Leu554Phe

CT

137

18 (13.1)

 
 

TT

    

TT

7

0 (0)

 

ENPP1

AA

600

64 (10.7)

0.75

SELE

AA

740

82 (11.1)

0.89

Gln121Lys

AC

192

24 (12.5)

 

Ser128Arg

AC

63

7 (11.1)

 
 

CC

15

2 (13.3)

  

CC

2

0 (0)

 

ESR1

CC

145

21 (14.5)

0.32

SELP

AA

646

71 (11)

0.48

-401T/C

CT

421

41 (9.7)

 

Thr715Pro

AC

150

19 (12.7)

 
 

TT

239

27 (11.3)

  

CC

9

0 (0)

 

F12

CC

459

51 (11.1)

0.73

TFPI

AA

   

46C/T

CT

283

32 (11.3)

 

Val264Met

AG

32

4 (12.5)

0.71

 

TT

49

7 (14.3)

  

GG

758

84 (11.1)

 

F13A1

GG

443

44 (9.9)

0.23

THBD

AA

   

Val34Leu

GT

296

39 (13.2)

 

-33G/A

AG

3

1 (33.3)

0.23

 

TT

41

7 (17.1)

  

GG

801

89 (11.1)

 

F2

AA

1

0 (0)

0.93

THBD

AA

11

2 (18.2)

0.46

G20210A*

AG

23

2 (8.7)

 

Ala25Thr

AG

794

87 (11)

 
 

GG

783

88 (11.2)

  

GG

   

F5

AA

1

0 (0)

0.26

THBD

CC

531

64 (12.1)

0.52

Arg506Gln

AG

36

1 (2.8)

 

Ala455Val

CT

237

22 (9.3)

 
 

GG

769

89 (11.6)

  

TT

24

2 (8.3)

 

F7

AA

16

5 (31.3)

0.01

THBS1

AA

614

66 (10.8)

0.65

Arg353Gln

AG

148

19 (12.8)

 

Asn700Ser

AG

177

23 (13)

 
 

GG

629

63 (10)

  

GG

14

1 (7.1)

 

FGB

AA

24

0 (0)

0.10

THBS2

GG

74

10 (13.5)

0.65

-455A/G

AG

247

23 (9.3)

 

3'UTR T/G*

GT

250

25 (10)

 
 

GG

533

67 (12.6)

  

TT

466

53 (11.4)

 

GJA4

CC

401

36 (9)

0.14

THBS4

CC

49

6 (12.2)

0.53

C1019T

CT

313

38 (12.1)

 

Ala387Pro

CG

268

34 (12.7)

 
 

TT

78

13 (16.7)

  

GG

486

49 (10.1)

 

GP1BA

CC

13

1 (7.7)

0.87

THPO

AA

187

25 (13.4)

0.52

-5T/C

CT

168

21 (12.5)

 

A5713G

AG

374

40 (10.7)

 
 

TT

597

66 (11.1)

  

GG

241

24 (10)

 

GRL

AA

756

83 (11)

0.68

TLR4

AA

702

85 (12.1)

0.10

Asn363Ser

AG

47

6 (12.8)

 

Gly299Asp

AG

88

4 (4.6)

 
 

GG

    

GG

1

0 (0)

 

HFE

AA

3

0 (0)

0.04

TNF

AA

24

4 (16.7)

0.43

Cys282Tyr

AG

96

18 (18.8)

 

-308G/A

AG

784

86 (11)

 
 

GG

703

70 (10)

  

GG

   

HTR2A

CC

286

25 (8.7)

0.13

TNFRSF1A

AA

17

0 (0)

0.29

Ser102Ser

CT

363

49 (13.5)

 

Arg92Gln

AG

189

19 (10.1)

 
 

TT

134

16 (11.9)

  

GG

597

71 (11.9)

 

9p21

GG

114

15 (13.2)

0.33

9p21

AA

175

23 (13.1)

0.28

rs10116277

GT

365

41 (11.2)

 

Rs10757274

AG

375

44 (11.7)

 
 

TT

243

20 (8.2)

  

GG

226

19 (8.4)

 

9p21

CC

118

11 (9.3)

0.24

     

Rs1333040

CT

332

44 (13.3)

 

9p21

AA

146

17 (11.6)

0.35

 

TT

306

28 (9.2)

 

Rs2383206

AG

375

46 (12.3)

 

9p21

AA

78

8 (10.3)

0.25

 

GG

249

21 (8.4)

 

Rs2383207**

AG

366

46 (12.6)

      
 

GG

268

22 (8.2)

      
  1. *HWE deviation (P < 0.05); **HWE deviation (P < 0.01)